Arvinas, Inc. (ARVN) vs Ovid Therapeutics (OVID)
Arvinas, Inc. and Ovid Therapeutics are both Biotechnology companies. Arvinas, Inc. and Ovid Therapeutics are of similar size ($509.4M and $487.3M). Ovid Therapeutics has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 18 metrics below, Arvinas, Inc. leads on 13 and Ovid Therapeutics on 5.
Valuation
Profitability
| Metric | ARVN | OVID | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 100.00% | 65.16% |
| Operating margin | (5.72%) | (742.97%) | 0.00% |
| Net margin | 2.94% | (439.11%) | 0.00% |
| Free cash flow margin | (65.93%) | (697.30%) | 0.00% |
| Return on equity | 1.59% | (25.97%) | (57.72%) |
| Return on assets | 1.17% | (22.30%) | (49.22%) |
| Return on invested capital | 0.00% | (35.11%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack